Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

HSV-1 targets lymphatic vessels in the eye and draining lymph node of mice leading to edema in the absence of a functional type I interferon response.

Bryant-Hudson KM, Chucair-Elliott AJ, Conrady CD, Cohen A, Zheng M, Carr DJ.

Am J Pathol. 2013 Oct;183(4):1233-42. doi: 10.1016/j.ajpath.2013.06.014. Epub 2013 Aug 2.

2.

Loss of mandibular lymph node integrity is associated with an increase in sensitivity to HSV-1 infection in CD118-deficient mice.

Conrady CD, Thapa M, Wuest T, Carr DJ.

J Immunol. 2009 Mar 15;182(6):3678-87. doi: 10.4049/jimmunol.0803878.

3.

VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis.

Wuest TR, Carr DJ.

J Exp Med. 2010 Jan 18;207(1):101-15. doi: 10.1084/jem.20091385. Epub 2009 Dec 21.

4.

Tumor necrosis factor alpha and interleukin-6 facilitate corneal lymphangiogenesis in response to herpes simplex virus 1 infection.

Bryant-Hudson KM, Gurung HR, Zheng M, Carr DJ.

J Virol. 2014 Dec;88(24):14451-7. doi: 10.1128/JVI.01841-14. Epub 2014 Oct 8.

5.

Type I interferon and lymphangiogenesis in the HSV-1 infected cornea - are they beneficial to the host?

Bryant-Hudson K, Conrady CD, Carr DJ.

Prog Retin Eye Res. 2013 Sep;36:281-91. doi: 10.1016/j.preteyeres.2013.06.003. Epub 2013 Jul 19. Review.

6.

Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection.

Conrady CD, Halford WP, Carr DJ.

J Virol. 2011 Feb;85(4):1625-33. doi: 10.1128/JVI.01715-10. Epub 2010 Dec 8.

8.

Cornea lymphatics drive the CD8+ T-cell response to herpes simplex virus-1.

Gurung HR, Carr MM, Carr DJ.

Immunol Cell Biol. 2017 Jan;95(1):87-98. doi: 10.1038/icb.2016.80. Epub 2016 Aug 31.

9.

Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.

Maehana S, Nakamura M, Ogawa F, Imai R, Murakami R, Kojima F, Majima M, Kitasato H.

Biomed Pharmacother. 2016 Dec;84:660-665. doi: 10.1016/j.biopha.2016.09.083. Epub 2016 Sep 30.

PMID:
27697638
10.

Molecular control of lymphatic metastasis.

Achen MG, Stacker SA.

Ann N Y Acad Sci. 2008;1131:225-34. doi: 10.1196/annals.1413.020. Review.

PMID:
18519975
11.

Reactive murine lymph nodes uniquely permit parenchymal access for T cells that enter via the afferent lymphatics.

Eidsmo L, Stock AT, Heath WR, Bedoui S, Carbone FR.

J Pathol. 2012 Apr;226(5):806-13. doi: 10.1002/path.3975. Epub 2012 Feb 17.

PMID:
22170282
12.

Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-gamma driven by the LAT promoter.

Ghiasi H, Osorio Y, Hedvat Y, Perng GC, Nesburn AB, Wechsler SL.

Virology. 2002 Oct 10;302(1):144-54.

13.

Simultaneous in vivo imaging of blood and lymphatic vessel growth in Prox1-GFP/Flk1::myr-mCherry mice.

Zhu J, Dugas-Ford J, Chang M, Purta P, Han KY, Hong YK, Dickinson ME, Rosenblatt MI, Chang JH, Azar DT.

FEBS J. 2015 Apr;282(8):1458-1467. doi: 10.1111/febs.13234. Epub 2015 Mar 6.

14.

CD8+ T cells suppress viral replication in the cornea but contribute to VEGF-C-induced lymphatic vessel genesis.

Conrady CD, Zheng M, Stone DU, Carr DJ.

J Immunol. 2012 Jul 1;189(1):425-32. doi: 10.4049/jimmunol.1200063. Epub 2012 May 30.

15.
16.

IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice.

Hendricks RL, Tumpey TM, Finnegan A.

J Immunol. 1992 Nov 1;149(9):3023-8.

PMID:
1401927
17.
18.

Interferon Regulator Factor 8 (IRF8) Limits Ocular Pathology during HSV-1 Infection by Restraining the Activation and Expansion of CD8+ T Cells.

Sun L, St Leger AJ, Yu CR, He C, Mahdi RM, Chan CC, Wang H, Morse HC 3rd, Egwuagu CE.

PLoS One. 2016 May 12;11(5):e0155420. doi: 10.1371/journal.pone.0155420. eCollection 2016.

20.

Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity?

Goyal S, Chauhan SK, El Annan J, Nallasamy N, Zhang Q, Dana R.

Arch Ophthalmol. 2010 Jul;128(7):819-24. doi: 10.1001/archophthalmol.2010.124.

Supplemental Content

Support Center